Genetron Health to Announce Fourth Quarter and Full Year 2020 Unaudited Financial Results and Host Investor Call on March 25, 2021

Rhea-AI Summary

Genetron Holdings Limited (NASDAQ:GTH), a leading precision oncology platform in China, announced it will report its unaudited financial results for Q4 and full year 2020 on March 25, 2021, prior to market open. Management will hold a conference call for investors at 8:30 a.m. ET on the same day. Genetron Health specializes in molecular profiling tests and cancer management, partnering with biopharmaceutical companies to enhance treatment options. The company emphasizes its commitment to transforming cancer care through advanced technologies.

Positive

• Scheduled reporting of unaudited financial results for Q4 and full year 2020 on March 25, 2021.
• Management will engage investors through a conference call, indicating transparency.

Negative

• None.

Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it will report unaudited financial results for the fourth quarter and full year ended December 31, 2020 on March 25, 2021 before the US market open.

Management will host a conference call for investors at 8:30 a.m. ET (8:30 p.m. Beijing time) on Thursday, March 25, 2021. The conference call can be accessed by dialing the following numbers:

United States:		+1-845-675-0437
China Domestic:		400-620-8038
Hong Kong:		+852-3018-6771
International:		+65-6713-5090
Conference ID:		5379298

Participants are encouraged to dial into the call at least 15 minutes in advance due to high call volumes.

A replay will be accessible through April 2, 2021 by dialing the following numbers:

Telco replay number

United States:		+1-855-452-5696
International:		+61-2-8199-0299
Conference ID:		5379298

A simultaneous webcast of the conference call will be available on the "News and Events" page of the Investors section of the Company's website. A replay of the webcast will be available for 30 days following the event. For more information, please visit ir.genetronhealth.com.

About Genetron Holdings Limited

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq:GTH) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products. For more information, please visit ir.genetronhealth.com.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210304006053/en/

FAQ

When will Genetron Holdings report its financial results?

Genetron Holdings will report its unaudited financial results for Q4 and the full year 2020 on March 25, 2021.

What time is Genetron's investor conference call?

The investor conference call will be held at 8:30 a.m. ET on March 25, 2021.

What does Genetron Holdings specialize in?

Genetron Holdings specializes in cancer molecular profiling and precision oncology solutions.

What is the significance of the upcoming financial results for GTH investors?

The upcoming financial results may provide insights into the company's performance and future prospects, impacting investor sentiment.